IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2023

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

IOVANCE BIOTHERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Intellectus Partners, LLC 120,029$845,0010.25%
Ghost Tree Capital, LLC 100,000$704,0000.23%
Brevan Howard Capital Management LP 1,481,435$10,429,3020.22%
HighVista Strategies LLC 66,526$468,3430.21%
Nikko Asset Management Americas, Inc. 2,490,600$17,508,9180.18%
Point72 Asset Management, L.P. 7,786,985$54,820,3740.16%
SEVEN EIGHT CAPITAL, LP 132,249$931,0330.15%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 65,000$456,9500.14%
C WorldWide Group Holding A/S 1,360,000$9,5740.12%
Quantamental Technologies LLC 40,384$284,3030.12%
ALGERT GLOBAL LLC 352,306$2,4800.11%
Dynamic Technology Lab Private Ltd 113,329$7980.10%
ROANOKE ASSET MANAGEMENT CORP/ NY 35,300$2490.10%
NinePointTwo Capital LLC 32,933$2310.09%
Candriam S.C.A. 1,727,816$12,163,8250.09%
HARBOR CAPITAL ADVISORS, INC. 56,341$396,6410.08%
Hennion & Walsh Asset Management, Inc. 181,531$1,2780.08%
PROFUND ADVISORS LLC 191,083$1,345,2240.07%
INNOVIS ASSET MANAGEMENT LLC 26,512$186,6450.07%
UBS OCONNOR LLC 289,384$2,037,2630.06%
External links

This page lists IOVANCE BIOTHERAPEUTICS INC's shareholders in Q2 2023. To view IOVANCE BIOTHERAPEUTICS INC's shareholder history, click here.